STOCK TITAN

New Clinical Evidence Workflow Solution From Wolters Kluwer Accelerates Research Activity Supporting Evidence-based Practice

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags
Rhea-AI Summary

Wolters Kluwer, Health has launched Ovid® Synthesis Clinical Evidence Manager, a cloud-based solution to enhance evidence-based research workflows in healthcare. Developed in collaboration with Duke Health and WVU Medicine, this software provides a centralized dashboard for tracking quality improvement (QI) projects. Key features include real-time project visibility, standardized workflows, integrated literature searches, and collaboration tools to streamline the implementation of new clinical practices based on current evidence, ultimately improving patient outcomes and financial performance.

Positive
  • Launch of Ovid Synthesis Clinical Evidence Manager enhances evidence-based research workflows.
  • Developed in collaboration with reputable healthcare institutions like Duke Health and WVU Medicine.
  • Centralized dashboard improves tracking and collaboration on quality improvement projects.
  • AI integration streamlines literature review and decision-making processes.
Negative
  • None.

Ovid Synthesis Clinical Evidence Manager simplifies evidence-based research projects enabling efficient implementation of new evidence into practice

WALTHAM, Mass.--(BUSINESS WIRE)-- Wolters Kluwer, Health today announced the launch of Ovid® Synthesis, a new suite of applications to power highly effective evidence-based workflows in the healthcare setting that complement Ovid’s premium medical content. The first Ovid Synthesis module, Clinical Evidence Manager, is a cloud-based workflow management solution that offers healthcare organizations a unique, centralized dashboard view of all quality improvement (QI) research projects for easier tracking and collaboration among teams to ensure new clinical practice improvements are based on the latest medical evidence.

“Evidence-based research initiatives at health systems hold the key to better patient outcomes and financial performance, but these programs are time-intensive making it difficult to efficiently surface and implement new evidence into clinical practice,” said Vikram Savkar, Senior Vice President & General Manager, Medicine Segment, Health Learning, Research & Practice business at Wolters Kluwer. “In the wake of a pandemic that laid bare the weaknesses of our current delivery system, we are bringing to market an important evidence-based practice (EBP) workflow solution that aims to improve the cycle between identification of clinical problems and implementation of clinical solutions based on the evidence.”

Ovid Synthesis Clinical Evidence Manager was developed in collaboration with Duke Health and the West Virginia University Health System (WVU Medicine), among other leading healthcare institutions. The expert solution streamlines the literature review and evidence appraisal process with artificial intelligence (AI), increases communication and collaboration among departments, and facilitates decisions on implementation. The solution supports a range of stakeholders with varying levels of research experience through easy-to-use tools and features including:

  • Executive and project level dashboards provide real-time visibility into projects across an institution
  • Standardized workflows with configurable templates to reflect organizational best practices
  • Integrated literature search directly within the system eliminates toggling between windows
  • Collaboration tools to promote team member interaction across sites help to cut costs and timelines
  • Built-in literature appraisal with configurable appraisal forms and AI-driven features to increase process efficiency
  • Automatic document generation of project findings in Microsoft Word and PowerPoint formats, including dynamically generated evidence tables

Learn more about Ovid Synthesis here.

About Wolters Kluwer

Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.

Wolters Kluwer reported 2020 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,200 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.

For more information, visit www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.

Media

André Rebelo

Sr. Global Public Relations Manager

Wolters Kluwer Health

+1 (781) 392-2411

andre.rebelo@wolterskluwer.com

Source: Wolters Kluwer Health

FAQ

What is the Ovid Synthesis Clinical Evidence Manager from Wolters Kluwer (WTKWY)?

Ovid Synthesis Clinical Evidence Manager is a cloud-based workflow management solution designed to enhance evidence-based research projects in healthcare, providing features like real-time project tracking and collaboration tools.

When was the Ovid Synthesis Clinical Evidence Manager launched by Wolters Kluwer (WTKWY)?

The Ovid Synthesis Clinical Evidence Manager was launched as part of a press release on January 10, 2022.

Who collaborated with Wolters Kluwer to develop the Clinical Evidence Manager (WTKWY)?

The Clinical Evidence Manager was developed in collaboration with Duke Health and West Virginia University Health System.

How does the Ovid Synthesis Clinical Evidence Manager improve healthcare workflows (WTKWY)?

It improves healthcare workflows by providing a centralized dashboard, AI-driven literature reviews, and collaboration tools that facilitate the tracking of quality improvement research projects.

WOLTERS KLUWER S/ADR

OTC:WTKWY

WTKWY Rankings

WTKWY Latest News

WTKWY Stock Data

40.50B
237.29M
0.04%
Specialty Business Services
Industrials
Link
United States of America
Alphen aan den Rijn